Simon Property Group Inc
Change company Symbol lookup
Select an option...
SPG Simon Property Group Inc
JNJ Johnson & Johnson
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
BROG Brooge Holdings Ltd
EMRAF Emera Inc
PG Procter & Gamble Co
CLOU Global X Cloud Computing ETF Global X Cloud Computing ETF
GDRX Goodrx Holdings Inc

Real Estate : Equity Real Estate Investment Trusts (REITs) | Mid Cap Value
Company profile

Simon Property Group, Inc. is a self-administered and self-managed real estate investment trust (REIT). The Company owns, develops and manages retail real estate properties, which consist primarily of malls, Premium Outlets and The Mills. Simon Property Group, L.P. (Operating Partnership), is the Company's partnership subsidiary that owns all of its real estate properties and other assets. As of December 31, 2016, the Company owned or held an interest in 206 income-producing properties in the United States, which consisted of 108 malls, 67 Premium Outlets, 14 Mills, four lifestyle centers, and 13 other retail properties in 37 states and Puerto Rico. As of December 31, 2016, it had redevelopment and expansion projects, including the addition of anchors, big box tenants, and restaurants, underway at 27 properties in the United States and it had one outlet and one other retail project under development.


Last Trade
0.65 (0.79%)
B/A Size

Market Hours

Closing Price
Day's Change
-2.98 (-3.48%)
B/A Size
Day's High
Day's Low

10-day average volume:

The 5th Annual Companion Diagnostics Forum on Oct 27-28 gathers scientists, clinicians, regulators and industry professionals for two days of web-based presentations

6:46 am ET October 20, 2020 (PR Newswire) Print

The 5th Annual Companion Diagnostics Forum will take place Tuesday and Wednesday, October 27-28, 2020. Register at

"The online Companion Diagnostics Forum is focused on the need for Companion Diagnostics to grow and keep pace with novel developments in Pharma," said Event Chair Oscar Puig from Eli Lilly, adding, "We are providing access to key people in this important field that are working every angle to ensure patients get the personalized medicine they require."

Keynote speaker Steve Anderson, CSO from Covance, explained that "Companion diagnostics are a critical component for delivering on the promise of precision medicine. This conference brings together industry leaders to discuss and review innovations and emerging applications in companion diagnostics."

Some of the therapeutic areas that will be covered are Oncology, ALS and trauma-related disorders. Education, regulations and adoption in clinical applications will be discussed at this year's forum. Speakers will address how these various areas are combining to bring better healthcare to patients.

Ronnye Schreiber, CEO, PlanetConnect and event organizer, said, "We are pleased that we can offer this custom virtual environment to ensure that the Forum could move forward even though we cannot meet in-person."

See a complete agenda and register online at

About PlanetConnect The Companion Diagnostics Forum is produced by PlanetConnect, a certified woman-owned conference producer and event production company with more than 25 years experience running scientific symposia for pharmaceutical, research, IT and manufacturing organizations. With decades of experience providing cost-effective, creative solutions, PlanetConnect enables companies to focus on making meaningful connections--not just meetings.

Contacts:Event Chair: Oscar Puig, Translational Medicine, Oncology Late Stage Development, Eli Lilly Event Manager: Ronnye Schreiber, CEO, PlanetConnect,

View original content:

SOURCE PlanetConnect

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.